Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tivantinib

EU orphan designation number: EU/3/13/1202   
Active ingredient: Tivantinib
Indication: Treatment of hepatocellular carcinoma
Sponsor: Daiichi Sankyo Development Ltd
Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire SL9 0BG, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/115/13 (2013)8048 of 13/11/2013